v3.26.1
Earnings (Loss) Per Share (Tables)
 6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Income (Loss) Per Share
The following tables set forth the computation of basic and diluted net income (loss) per share of common stock:
Three Months Ended June 30,
(in millions, except shares and per share amounts)
20262025
Basic net income (loss) per share attributable to common stockholders
Numerator:
Net income (loss)$(643.7)$24.0 
Denominator:
Weighted average number of shares of common stock outstanding294,503,465 327,242,789 
Basic net income (loss) per share attributable to common stockholders$(2.19)$0.07 
Diluted net income (loss) per share attributable to common stockholders
Numerator:
Net income (loss)$(643.7)$24.0 
Denominator:
Weighted average shares of common stock outstanding used to calculate diluted net income (loss) per share294,503,465 327,242,789 
Diluted net income (loss) per share attributable to common stockholders$(2.19)$0.07 
Six Months Ended June 30,
(in millions, except shares and per share amounts)
20262025
Basic net income (loss) per share attributable to common stockholders
Numerator:
Net income (loss)$(614.4)$50.8 
Denominator:
Weighted average number of shares of common stock outstanding298,477,470 333,992,323 
Basic net income (loss) per share attributable to common stockholders$(2.06)$0.15 
Diluted net income (loss) per share attributable to common stockholders
Numerator:
Net income (loss)$(614.4)$50.8 
Denominator:
Weighted average shares of common stock outstanding used to calculate diluted net income (loss) per share298,477,470 333,992,323 
Diluted net income (loss) per share attributable to common stockholders$(2.06)$0.15 
Schedule of Potential Common Stock Equivalents Excluded from Calculation of Diluted Net Income (Loss) Per Share Potentially dilutive securities excluded due to their anti-dilutive effect were as follows:
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Restricted stock units22,369,079 17,305,281 18,251,642 15,459,826 
CEO Premium-Priced Performance Option9,678,000 — 9,678,000 — 
Liability-classified awards171,084 — 171,084 — 
Exercise of common stock options186,307 264,746 187,661 245,835 
Total anti-dilutive securities32,404,470 17,570,027 28,288,387 15,705,661